Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations     ATC     Antiinfectives for Systemic Use     Vaccines     Animal Vaccines     European Live attenuated vaccines Market    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Asian Live attenuated vaccines Market Research Report

  • Report Code: LI 1001
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The Asian live attenuated animal vaccine market, mainly driven by growing prevalence of animal diseases, was valued at $428 million in 2013, and expected to be $745 million by 2018 at a CAGR of 11.7%. Live attenuated vaccines for poultry have a dominant share compared to the rest, since the spray method is more popularly used for poultry vaccinations.

 

‘The Asian Live Attenuated Animal Vaccine Market, 2012-2018’ analyzes the market by products such as aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The types of the market are preventive and therapeutic. The market experiences a positive growth owing to its presence and requirement in all the segments.

 

Live attenuated vaccines are relatively easy to create for certain viruses. Vaccines against measles, mumps, and Varicella (chickenpox), for example, are made by this method. Rubella (MMR combined vaccine), Influenza (nasal spray), and Rotavirus are some other examples. The Univax-BD, Univax Plus, Trachivax, Shor-Bron-D, and Vista Once SQ are a few examples of live attenuated vaccines.

 

Asian countries are a potential markets for the animal vaccines market with a huge number of domesticated animals, such as dogs, chicken, cattle, and pigs. The animal vaccines market in the Asian region has changed remarkably over the past few years, and will continue to grow what with the growing numbers of people adopting pets, especially in India and China.

 

The report also provides an extensive competitive landscaping of companies operating in this market. The main companies are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. Segment and country-specific company shares, news & deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed.

 

Customization Options

Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (segment wise)
  • Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
  • End-user adoption rate analysis of the products (segment wise and country wise)
  • Comprehensive coverage of product approvals, pipeline products, and product recalls

 

Epidemiology Data

  • Country-specific prevalence of infectious bursal disease vaccine, bovine viral diarrhea (BVD), foot and mouth diseases, and swine influenza
  • Country-specific patient pool infectious bursal disease vaccine, bovine viral diarrhea (BVD), foot and mouth diseases, and swine influenza
  • Disease progression (pattern analysis)

 

Surgeons/Physicians Forum

  • Fast turn-around analysis of surgeons’ response to market events and trends
  • Pattern analysis of usage of live attenuated vaccines by physicians
  • Surgeons’ opinion about products from different companies
  • Surgeons’ qualitative inputs on epidemiology data

 

Perception Matrix

  • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

 

Competitive Intelligence

  • The company share analysis of the top players in the Asian live attenuated vaccines market
  • The crucial developments and strategies of companies inculcated in their portfolio for the Asian live attenuated vaccines market

 

Alternative Products: Impact analysis

MMM’s healthcare decision making quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of research laboratories, number of hospitals and clinics, diagnosis rate, treatment rate and healthcare expenditure).



1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Live attenuated vaccines-Asia, By Types
4.1 Split By Geography
4.1 Live attenuated vaccines-Asia - Japan by Types
4.1 Live attenuated vaccines-China by Types
4.1 Live attenuated vaccines-India by Types
4.1 Live attenuated vaccines-Asia - Other Geographies by Types
4.2 Live attenuated vaccines-Preventive-Asia
4.2.1 Live attenuated vaccines-Preventive-Asia, By Products
4.2.1.1 Live attenuated vaccines-Preventive-Asia-Livestock
4.2.1.2 Live attenuated vaccines-Preventive-Asia-Poultry
4.2.1.3 Live attenuated vaccines-Preventive-Asia-Porcine
4.2.1.4 Live attenuated vaccines-Preventive-Asia-Companion animal vaccines
4.2.1.5 Live attenuated vaccines-Preventive-Asia-Equine
4.2.1.6 Live attenuated vaccines-Preventive-Asia-Aquaculture
4.2.2 Live attenuated vaccines-Preventive-Asia, By Geographies
4.2.2.1 Live attenuated vaccines-Preventive-Asia - Japan
4.2.2.2 Live attenuated vaccines-Preventive-China
4.2.2.3 Live attenuated vaccines-Preventive-India
4.2.2.4 Live attenuated vaccines-Preventive-Asia - Other Geographies
4.3 Live attenuated vaccines-Therapeutic-Asia
4.3.1 Live attenuated vaccines-Therapeutic-Asia, By Products
4.3.1.1 Live attenuated vaccines-Therapeutic-Asia-Livestock
4.3.1.2 Live attenuated vaccines-Therapeutic-Asia-Poultry
4.3.1.3 Live attenuated vaccines-Therapeutic-Asia-Porcine
4.3.1.4 Live attenuated vaccines-Therapeutic-Asia-Companion animal vaccines
4.3.1.5 Live attenuated vaccines-Therapeutic-Asia-Equine
4.3.1.6 Live attenuated vaccines-Therapeutic-Asia-Aquaculture
4.3.2 Live attenuated vaccines-Therapeutic-Asia, By Geographies
4.3.2.1 Live attenuated vaccines-Therapeutic-Asia - Japan
4.3.2.2 Live attenuated vaccines-Therapeutic-China
4.3.2.3 Live attenuated vaccines-Therapeutic-India
4.3.2.4 Live attenuated vaccines-Therapeutic-Asia - Other Geographies
5 Live attenuated vaccines-Asia, By Products
5.1 Split By Geography
5.2 Live attenuated vaccines-Asia - Japan by Products
5.1 Live attenuated vaccines-China by Products
5.1 Live attenuated vaccines-India by Products
5.1 Live attenuated vaccines-Asia - Other Geographies by Products
5.2 Live attenuated vaccines-Asia-Livestock
5.2.1 Live attenuated vaccines-Asia-Livestock, By Types
5.2.1.1 Live attenuated vaccines-Preventive-Asia-Livestock
5.2.1.2 Live attenuated vaccines-Therapeutic-Asia-Livestock
5.3 Live attenuated vaccines-Asia-Poultry
5.3.1 Live attenuated vaccines-Asia-Poultry, By Types
5.3.1.1 Live attenuated vaccines-Preventive-Asia-Poultry
5.3.1.2 Live attenuated vaccines-Therapeutic-Asia-Poultry
5.4 Live attenuated vaccines-Asia-Porcine
5.4.1 Live attenuated vaccines-Asia-Porcine, By Types
5.4.1.1 Live attenuated vaccines-Preventive-Asia-Porcine
5.4.1.2 Live attenuated vaccines-Therapeutic-Asia-Porcine
5.5 Live attenuated vaccines-Asia-Companion animal vaccines
5.5.1 Live attenuated vaccines-Asia-Companion animal vaccines, By Types
5.5.1.1 Live attenuated vaccines-Preventive-Asia-Companion animal vaccines
5.5.1.2 Live attenuated vaccines-Therapeutic-Asia-Companion animal vaccines
5.6 Live attenuated vaccines-Asia-Equine
5.6.1 Live attenuated vaccines-Asia-Equine, By Types
5.6.1.1 Live attenuated vaccines-Preventive-Asia-Equine
5.6.1.2 Live attenuated vaccines-Therapeutic-Asia-Equine
5.7 Live attenuated vaccines-Asia-Aquaculture
5.7.1 Live attenuated vaccines-Asia-Aquaculture, By Types
5.7.1.1 Live attenuated vaccines-Preventive-Asia-Aquaculture
5.7.1.2 Live attenuated vaccines-Therapeutic-Asia-Aquaculture
6 Live attenuated vaccines-Asia, By Geographies
6.1 Live attenuated vaccines-Asia - Japan
6.1.1 Live attenuated vaccines-Asia - Japan, By Types
6.1.1.1 Live attenuated vaccines-Preventive-Asia - Japan
6.1.1.2 Live attenuated vaccines-Therapeutic-Asia - Japan
6.1.2 Live attenuated vaccines-Asia - Japan, By Companies
6.1.2.1 Live attenuated vaccines-Asia - Japan-Other Companies
6.1.2.2 Live attenuated vaccines-Asia - Japan-Pfizer Inc
6.1.2.3 Live attenuated vaccines-Asia - Japan-Sanofi-Aventis U.S.
6.1.2.4 Live attenuated vaccines-Asia - Japan-Merck & Co., Inc.
6.1.2.5 Live attenuated vaccines-Asia - Japan-Virbac
6.1.2.6 Live attenuated vaccines-Asia - Japan-Bayer Healthcare
6.2 Live attenuated vaccines-China
6.2.1 Live attenuated vaccines-China, By Types
6.2.1.1 Live attenuated vaccines-Preventive-China
6.2.1.2 Live attenuated vaccines-Therapeutic-China
6.2.2 Live attenuated vaccines-China, By Companies
6.2.2.1 Live attenuated vaccines-China-Other Companies
6.2.2.2 Live attenuated vaccines-China-Pfizer Inc
6.2.2.3 Live attenuated vaccines-China-Sanofi-Aventis U.S.
6.2.2.4 Live attenuated vaccines-China-Merck & Co., Inc.
6.2.2.5 Live attenuated vaccines-China-Virbac
6.2.2.6 Live attenuated vaccines-China-Bayer Healthcare
6.3 Live attenuated vaccines-India
6.3.1 Live attenuated vaccines-India, By Types
6.3.1.1 Live attenuated vaccines-Preventive-India
6.3.1.2 Live attenuated vaccines-Therapeutic-India
6.3.2 Live attenuated vaccines-India, By Companies
6.3.2.1 Live attenuated vaccines-India-Other Companies
6.3.2.2 Live attenuated vaccines-India-Pfizer Inc
6.3.2.3 Live attenuated vaccines-India-Sanofi-Aventis U.S.
6.3.2.4 Live attenuated vaccines-India-Merck & Co., Inc.
6.3.2.5 Live attenuated vaccines-India-Virbac
6.3.2.6 Live attenuated vaccines-India-Bayer Healthcare
6.4 Live attenuated vaccines-Asia - Other Geographies
6.4.1 Live attenuated vaccines-Asia - Other Geographies, By Types
6.4.1.1 Live attenuated vaccines-Preventive-Asia - Other Geographies
6.4.1.2 Live attenuated vaccines-Therapeutic-Asia - Other Geographies
6.4.2 Live attenuated vaccines-Asia - Other Geographies, By Companies
6.4.2.1 Live attenuated vaccines-Asia - Other Geographies-Other Companies
6.4.2.2 Live attenuated vaccines-Asia - Other Geographies-Pfizer Inc
6.4.2.3 Live attenuated vaccines-Asia - Other Geographies-Sanofi-Aventis U.S.
6.4.2.4 Live attenuated vaccines-Asia - Other Geographies-Merck & Co., Inc.
6.4.2.5 Live attenuated vaccines-Asia - Other Geographies-Virbac
6.4.2.6 Live attenuated vaccines-Asia - Other Geographies-Bayer Healthcare
7 Live attenuated vaccines-Asia, By Companies
7.1 Competitive landscape
7.2 Split By Geography
7.3 Live attenuated vaccines-Asia - Japan by Companies
7.1 Live attenuated vaccines-China by Companies
7.1 Live attenuated vaccines-India by Companies
7.1 Live attenuated vaccines-Asia - Other Geographies by Companies
7.3 Live attenuated vaccines-Asia-Other Companies
7.3.1 Live attenuated vaccines-Asia-Other Companies, By Geographies
7.3.1.1 Live attenuated vaccines-Asia - Japan-Other Companies
7.3.1.2 Live attenuated vaccines-China-Other Companies
7.3.1.3 Live attenuated vaccines-India-Other Companies
7.3.1.4 Live attenuated vaccines-Asia - Other Geographies-Other Companies
7.4 Live attenuated vaccines-Asia-Pfizer Inc
7.4.1 Live attenuated vaccines-Asia-Pfizer Inc, By Geographies
7.4.1.1 Live attenuated vaccines-Asia - Japan-Pfizer Inc
7.4.1.2 Live attenuated vaccines-China-Pfizer Inc
7.4.1.3 Live attenuated vaccines-India-Pfizer Inc
7.4.1.4 Live attenuated vaccines-Asia - Other Geographies-Pfizer Inc
7.5 Live attenuated vaccines-Asia-Sanofi-Aventis U.S.
7.5.1 Live attenuated vaccines-Asia-Sanofi-Aventis U.S., By Geographies
7.5.1.1 Live attenuated vaccines-Asia - Japan-Sanofi-Aventis U.S.
7.5.1.2 Live attenuated vaccines-China-Sanofi-Aventis U.S.
7.5.1.3 Live attenuated vaccines-India-Sanofi-Aventis U.S.
7.5.1.4 Live attenuated vaccines-Asia - Other Geographies-Sanofi-Aventis U.S.
7.6 Live attenuated vaccines-Asia-Merck & Co., Inc.
7.6.1 Live attenuated vaccines-Asia-Merck & Co., Inc., By Geographies
7.6.1.1 Live attenuated vaccines-Asia - Japan-Merck & Co., Inc.
7.6.1.2 Live attenuated vaccines-China-Merck & Co., Inc.
7.6.1.3 Live attenuated vaccines-India-Merck & Co., Inc.
7.6.1.4 Live attenuated vaccines-Asia - Other Geographies-Merck & Co., Inc.
7.7 Live attenuated vaccines-Asia-Virbac
7.7.1 Live attenuated vaccines-Asia-Virbac, By Geographies
7.7.1.1 Live attenuated vaccines-Asia - Japan-Virbac
7.7.1.2 Live attenuated vaccines-China-Virbac
7.7.1.3 Live attenuated vaccines-India-Virbac
7.7.1.4 Live attenuated vaccines-Asia - Other Geographies-Virbac
7.8 Live attenuated vaccines-Asia-Bayer Healthcare
7.8.1 Live attenuated vaccines-Asia-Bayer Healthcare, By Geographies
7.8.1.1 Live attenuated vaccines-Asia - Japan-Bayer Healthcare
7.8.1.2 Live attenuated vaccines-China-Bayer Healthcare
7.8.1.3 Live attenuated vaccines-India-Bayer Healthcare
7.8.1.4 Live attenuated vaccines-Asia - Other Geographies-Bayer Healthcare

Please fill in the form below to receive a free copy of the Summary of this Report
















Asian Live attenuated vaccines Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Connect With Us
US/CAN : +1-888-502-0539